跳至主要内容
临床试验/NCT01667042
NCT01667042已完成不适用

Scleroderma Lung: Role of Gastroesophageal Reflux, Microaspiration and Cough

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 7 人开始时间: 2012年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
7
试验地点
1
主要终点
Airway pepsin concentration

研究概览

简要总结

This is a mechanistic research study to evaluate the relationship between cough, reflux, and aspiration in patients with systemic sclerosis (scleroderma).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients ≥ 18 years old.
  • Fulfilling the American College of Rheumatology criteria for SSc.
  • For ILD subgroup (n=6):
  • An upright chest-roentgenogram (chest x-ray) is abnormal and compatible with an interstitial lung disease.
  • HRCT of the chest confirms the presence of bilateral reticular, ground glass, and/or honeycomb abnormalities that is otherwise unexplained by an alternative process
  • The HRCT fibrosis score must be ≥
  • The total lung capacity (TLC, measured by body plethysmography) and/or the diffusing capacity of the lung for carbon monoxide (DLCO) is below the predicted normal.
  • The forced vital capacity (FVC) is reduced below the predicted normal.
  • The patient is symptomatic (i.e. dyspnea and/or a chronic cough) for more than 8 weeks that is otherwise unexplained by an alternative mechanism.
  • For No ILD subgroup (n=6):
  • No radiographic evidence of ILD on plain chest x-ray.
  • The HRCT fibrosis score, when performed) must be < 7
  • The TLC and FVC are within their predicted normal.
  • The DLCO is within the predicted normal, except when reduced in isolation by pulmonary hypertension.

排除标准

  • Active smoking within the 6 months.
  • Pneumonia or bronchitis in past 4 weeks.
  • Active acute illness such as uncontrolled heart failure, infection, or asthma.
  • Use of more than 3 liters per minute (LPM) of oxygen by nasal cannula at rest.
  • Coordinator, investigator, or clinician concerns on the patient's compliance, safety, or in ability to complete study requirements.
  • Morbid condition not expected to live more than 1 year.
  • Alternative cause or diagnosis for the patient's ILD besides SSc.
  • Pregnancy.
  • Obstructive lung disease with an FEV1 (forced expiratory volume in 1 second) to FVC ratio less than 0.7, nor radiographic evidence of emphysema on CT.
  • Planned therapeutic procedures involving the esophagus (e.g. dilation, surgery) prior to completion of study tests

结局指标

主要结局

Airway pepsin concentration

时间窗: cross-sectional

Cross-sectional comparison between airway pepsin level, cough frequency, FVC, DLCO, and CT fibrosis score

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Augustine S. Lee

M.D.

Mayo Clinic

研究点 (1)

Loading locations...

相似试验

Scleroderma Lung: Role of Gastroesophageal Reflux,... | 临床试验